Lataa...

Extended Adjuvant Aromatase Inhibitor Therapy in Post-Menopausal Women

PURPOSE OF THE REVIEW: To understand the evidence for extending adjuvant aromatase inhibitor (AI) therapy from 5 to 10 years in post-menopausal women with hormone receptor positive (HR+) breast cancer. RECENT FINDINGS: Multiple large trials have investigated this question. The two trials most repres...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Curr Breast Cancer Rep
Päätekijät: Schleicher, Stephen M., Dickler, Maura N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5791913/
https://ncbi.nlm.nih.gov/pubmed/29399271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-017-0260-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!